1.

Assessing the introduction risk of vector-borne animal diseases for the Netherlands using MINTRISK : A Model for INTegrated RISK assessment

2.

Assessing the introduction risk of vector-borne animal diseases for the Netherlands using MINTRISK : A Model for INTegrated RISK assessment

1.

Assessing the introduction risk of vector-borne animal diseases for the Netherlands using MINTRISK: A Model for INTegrated RISK assessment.

2.

Assessing the introduction risk of vector-borne animal diseases for the Netherlands using MINTRISK: A Model for INTegrated RISK assessment.

1.

Assessing the introduction risk of vector-borne animal diseases for the Netherlands using MINTRISK: A Model for INTegrated RISK assessment

2.

Assessing the introduction risk of vector-borne animal diseases for the Netherlands using MINTRISK: A Model for INTegrated RISK assessment

3.

Assessing the introduction risk of vector-borne animal diseases for the Netherlands using MINTRISK: A Model for INTegrated RISK assessment

4.

Assessing the introduction risk of vector-borne animal diseases for the Netherlands using MINTRISK: A Model for INTegrated RISK assessment

5.

Assessing the introduction risk of vector-borne animal diseases for the Netherlands using MINTRISK: A Model for INTegrated RISK assessment

1.

Cost-Effectiveness of Hepatitis C Treatment for People Who Inject Drugs and the Impact of the Type of Epidemic; Extrapolating from Amsterdam, the Netherlands.

2.

Cost-Effectiveness of Hepatitis C Treatment for People Who Inject Drugs and the Impact of the Type of Epidemic; Extrapolating from Amsterdam, the Netherlands.

1.

Dietary based caries risk in the Belgian population, results of the first national oral health survey

2.

Dietary based caries risk in the Belgian population, results of the first national oral health survey

3.

Dietary based caries risk in the Belgian population, results of the first national oral health survey

4.

Dietary based caries risk in the Belgian population, results of the first national oral health survey

5.

Dietary based caries risk in the Belgian population, results of the first national oral health survey

6.

Dietary based caries risk in the Belgian population, results of the first national oral health survey

1.

Clinical and scientific aspects related to biosimilars in inflammatory bowel diseases (IBD): position document of the Belgian IBD Research & Development Group (BIRD)

2.

Clinical and scientific aspects related to biosimilars in inflammatory bowel diseases (IBD): position document of the Belgian IBD Research & Development Group (BIRD)

3.

Clinical and scientific aspects related to biosimilars in inflammatory bowel diseases (IBD): position document of the Belgian IBD Research & Development Group (BIRD)

4.

Clinical and scientific aspects related to biosimilars in inflammatory bowel diseases (IBD): position document of the Belgian IBD Research & Development Group (BIRD)

1.

Belgian IBD research group (BIRD) position statement 2017 on the use of biosimilars in inflammatory bowel diseases (IBD).

2.

Belgian IBD research group (BIRD) position statement 2017 on the use of biosimilars in inflammatory bowel diseases (IBD).

3.

Belgian IBD research group (BIRD) position statement 2017 on the use of biosimilars in inflammatory bowel diseases (IBD).

4.

Belgian IBD research group (BIRD) position statement 2017 on the use of biosimilars in inflammatory bowel diseases (IBD).

5.

Belgian IBD research group (BIRD) position statement 2017 on the use of biosimilars in inflammatory bowel diseases (IBD).

6.

Belgian IBD research group (BIRD) position statement 2017 on the use of biosimilars in inflammatory bowel diseases (IBD).

7.

Belgian IBD research group (BIRD) position statement 2017 on the use of biosimilars in inflammatory bowel diseases (IBD).

8.

Belgian IBD research group (BIRD) position statement 2017 on the use of biosimilars in inflammatory bowel diseases (IBD).

9.

Belgian IBD research group (BIRD) position statement 2017 on the use of biosimilars in inflammatory bowel diseases (IBD).

1.

Organic acid production from potato starch waste fermentation by rumen microbial communities from Dutch and Thai dairy cows

2.

Organic acid production from potato starch waste fermentation by rumen microbial communities from Dutch and Thai dairy cows

3.

Organic acid production from potato starch waste fermentation by rumen microbial communities from Dutch and Thai dairy cows

4.

Organic acid production from potato starch waste fermentation by rumen microbial communities from Dutch and Thai dairy cows

5.

Organic acid production from potato starch waste fermentation by rumen microbial communities from Dutch and Thai dairy cows

6.

Organic acid production from potato starch waste fermentation by rumen microbial communities from Dutch and Thai dairy cows

7.

Organic acid production from potato starch waste fermentation by rumen microbial communities from Dutch and Thai dairy cows

8.

Organic acid production from potato starch waste fermentation by rumen microbial communities from Dutch and Thai dairy cows

9.

Organic acid production from potato starch waste fermentation by rumen microbial communities from Dutch and Thai dairy cows

1.

Platelet-Rich plasma Injection Management for Ankle osteoarthritis study (PRIMA): protocol of a Dutch multicentre, stratified, block-randomised, double-blind, placebo-controlled tr...

2.

Platelet-Rich plasma Injection Management for Ankle osteoarthritis study (PRIMA): protocol of a Dutch multicentre, stratified, block-randomised, double-blind, placebo-controlled tr...

3.

Platelet-Rich plasma Injection Management for Ankle osteoarthritis study (PRIMA): protocol of a Dutch multicentre, stratified, block-randomised, double-blind, placebo-controlled tr...

4.

Platelet-Rich plasma Injection Management for Ankle osteoarthritis study (PRIMA): protocol of a Dutch multicentre, stratified, block-randomised, double-blind, placebo-controlled tr...

5.

Platelet-Rich plasma Injection Management for Ankle osteoarthritis study (PRIMA): protocol of a Dutch multicentre, stratified, block-randomised, double-blind, placebo-controlled tr...

6.

Platelet-Rich plasma Injection Management for Ankle osteoarthritis study (PRIMA): protocol of a Dutch multicentre, stratified, block-randomised, double-blind, placebo-controlled tr...

7.

Platelet-Rich plasma Injection Management for Ankle osteoarthritis study (PRIMA): protocol of a Dutch multicentre, stratified, block-randomised, double-blind, placebo-controlled tr...

8.

Platelet-Rich plasma Injection Management for Ankle osteoarthritis study (PRIMA): protocol of a Dutch multicentre, stratified, block-randomised, double-blind, placebo-controlled tr...

9.

Platelet-Rich plasma Injection Management for Ankle osteoarthritis study (PRIMA): protocol of a Dutch multicentre, stratified, block-randomised, double-blind, placebo-controlled tr...

1.

Genome sequence analysis of a Belgian epidemic cystic fibrosis Pseudomonas aeruginosa isolate

2.

Genome sequence analysis of a Belgian epidemic cystic fibrosis Pseudomonas aeruginosa isolate

3.

Genome sequence analysis of a Belgian epidemic cystic fibrosis Pseudomonas aeruginosa isolate

4.

Genome sequence analysis of a Belgian epidemic cystic fibrosis Pseudomonas aeruginosa isolate

5.

Genome sequence analysis of a Belgian epidemic cystic fibrosis Pseudomonas aeruginosa isolate

6.

Genome sequence analysis of a Belgian epidemic cystic fibrosis Pseudomonas aeruginosa isolate

7.

Genome sequence analysis of a Belgian epidemic cystic fibrosis Pseudomonas aeruginosa isolate

8.

Genome sequence analysis of a Belgian epidemic cystic fibrosis Pseudomonas aeruginosa isolate

9.

Genome sequence analysis of a Belgian epidemic cystic fibrosis Pseudomonas aeruginosa isolate